New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
November 22, 2009
17:20 EDTAZN
theflyonthewall.com: U.S. Court of Appeals upholds AstraZeneca AWP settlement
The United States Court of Appeals for the First Circuit upheld an earlier District Court ruling, approving a settlement in the long-running Average Wholesale Price-AWP-pharmaceutical litigation against AstraZeneca Pharmaceuticals .The ruling affirms a settlement that awarded consumers who purchased the pharmaceutical giant's prostate cancer drug Zoladex treble damages, a rare if not unprecedented event in consumer litigation. The case afforded thousands of consumers access to a $24M settlement against the drug giant accused of manipulating the price of Zoladex. Under the settlement approved by the U.S. District Court in November 2007, any consumer who could provide reasonable documentation can receive three times the actual damages. Any funds left over from the $24M settlement would go to non-profit organizations. Experts representing the plaintiffs expect that only about $21M will be claimed by class members, many of whom have passed away since the case was filed. :theflyonthewall.com



News For AZN From The Last 14 Days
Check below for free stories on AZN the last two weeks.
There are 14 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 10, 2012
08:37 EDTAZN
theflyonthewall.com: AstraZeneca management to meet with JPMorgan

Subscribe for More Information
:theflyonthewall.com

February 8, 2012
09:01 EDTAZN
theflyonthewall.com: AstraZeneca broadens income eligibility for prescription savings programs

Subscribe for More Information
:theflyonthewall.com

February 7, 2012
07:20 EDTAZN
theflyonthewall.com: AstraZeneca downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrll downgraded AstraZeneca citing weak fundamentals. Price target lowered to $49.20 from $50.70. :theflyonthewall.com

February 2, 2012
16:50 EDTAZN
theflyonthewall.com: On The Fly: Closing Wrap

Subscribe for More Information
:theflyonthewall.com
12:18 EDTAZN
theflyonthewall.com: On The Fly: Mid-Day Wrap

Subscribe for More Information
:theflyonthewall.com
05:47 EDTAZN
theflyonthewall.com: AstraZeneca reaffirms 2010-2014 revenue target of $28B-$34B per year

Subscribe for More Information
:theflyonthewall.com
05:45 EDTAZN
theflyonthewall.com: AstraZeneca announces plan for $4.5B in share repurchases in 2012

Subscribe for More Information
:theflyonthewall.com
05:45 EDTAZN
theflyonthewall.com: AstraZeneca recommends 10% annual dividend increase to $2.80
AstraZeneca said its board has recommended a 5% increase in the second interim dividend to $1.95 to be paid on March 19. This brings the full year dividend to $2.80, an increase of 10%. :theflyonthewall.com
05:44 EDTAZN
theflyonthewall.com: AstraZeneca sees 2012 core EPS $6.00-$6.30 vs. consensus $6.06

Subscribe for More Information
:theflyonthewall.com
05:41 EDTAZN
theflyonthewall.com: AstraZeneca reports Q4 core EPS $1.61 vs. consensus $1.56
Reports Q4 revenue $8.67B vs. consensus $8.59B. :theflyonthewall.com
05:40 EDTAZN
theflyonthewall.com: AstraZeneca to cut 7,300 positions in restructuring program

Subscribe for More Information
:theflyonthewall.com

January 30, 2012
15:51 EDTAZN
theflyonthewall.com: Biotech Industry Organization to host a conference

Subscribe for More Information
:theflyonthewall.com
07:29 EDTAZN
theflyonthewall.com: The FDA Pediatric Advisory Committee to hold a meeting
The Committee discusses pediatric-focused safety reviews, as mandated by Best Pharmaceuticals for Children Act and Pediatric Research Equity Act for Novartis Pharmaceuticals' Focalin XR, Shire's Daytrana, AstraZeneca's Seroquel and Atacand, Johnson & Johnson's Pancreaze, Eurand's Zenpep, Solvay Pharma's Creon, Meda Pharma's Xerese cream, Genentech's Xolair, Daiichi Sankyo's Benicar, Bayer's Mirena and Plan B One Step, and Boehringer Ingelheim's Flomax in a meeting to be held in Gaithersburg, Maryland on January 30 at 8 am. Webcast Link :theflyonthewall.com
06:12 EDTAZN
theflyonthewall.com: AstraZeneca may announce $3B extension to repurchase program, Independent says

Subscribe for More Information
:theflyonthewall.com